Galanthamine hydrobromide is a selective, reversible, competitive, alkaloid AChE inhibitor.

Podofilox (Podophyllotoxin) is a potent inhibitor of microtubule assembly and DNA topoisomerase II.

Camptothecin, a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor.

Triptolide is a diterpenoid triepoxide and acts as an NF-κB activation inhibitor.

Ursodeoxycholic acid is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting through interactions with bile acid-activated receptors including TGR5 and FXR.

Eriodictyol is an active TRPV1 receptor antagonist.

Lovastatin is a cell-permeable HMG-CoA reductase inhibitor.

Methoxsalen is a furanocoumarin compound and a cytochrome P450 inhibitor.

Molnupiravir is an isopropyl ester prodrug of the ribonucleoside analog EIDD‑1931.

Apremilast is an inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4).

Pomalidomide, the third-generation immunomodulatory agent, acts as molecular glue.

Rifapentine is an antibiotic that can be used in the study of tuberculosis.

Scopolamine hydrobromide is a high-affinity muscarinic antagonist that can cross the blood-brain barrier.

Digoxin is a potent inhibitor of Na+/K+-ATPase.

Mivacurium chloride is a benzylisoquinoline derivative that couples with nAChR to reduce or inhibit the depolarizing effect of acetylcholine on the motor endplate of muscle cells.

Rifampicin is a potent and broad spectrum antibiotic.